Literature DB >> 20103632

BRCA1 represses amphiregulin gene expression.

Ekaterina P Lamber1, Andrew A Horwitz, Jeffrey D Parvin.   

Abstract

BRCA1, the breast cancer- and ovarian cancer-specific tumor suppressor, can be a transcriptional repressor or a transcriptional activator, depending on the promoter context. To identify the genes activated or repressed by BRCA1, we have analyzed microarray results from cells depleted of BRCA1 and revealed a number of genes regulated by BRCA1 on the level of transcription. Among the genes repressed by BRCA1, we have identified amphiregulin (AREG) and early growth response-1 (EGR1). Results indicate that BRCA1 regulates AREG transcription directly through binding to the AREG promoter, however, we could not detect BRCA1 on the EGR1 promoter, suggesting that EGR1 is indirectly regulated by BRCA1. In an attempt to identify the mechanism of the AREG transcriptional repression by BRCA1, we have mapped two independent BRCA1 response elements on the AREG located at positions -202/-182 and +19/+122. BRCA1 depletion leads to induction of the AREG protein. Taken together, our data build the connection between BRCA1 loss of function and AREG upregulation-a change in gene expression often observed in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20103632      PMCID: PMC2816672          DOI: 10.1158/0008-5472.CAN-09-2842

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  48 in total

1.  Transcriptional activation by BRCA1.

Authors:  M S Chapman; I M Verma
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

2.  BRCA1 is a component of the RNA polymerase II holoenzyme.

Authors:  R Scully; S F Anderson; D M Chao; W Wei; L Ye; R A Young; D M Livingston; J D Parvin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

3.  Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells.

Authors:  X Xu; Z Weaver; S P Linke; C Li; J Gotay; X W Wang; C C Harris; T Ried; C X Deng
Journal:  Mol Cell       Date:  1999-03       Impact factor: 17.970

4.  Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.

Authors:  G Fontanini; M De Laurentiis; S Vignati; S Chinè; M Lucchi; V Silvestri; A Mussi; S De Placido; G Tortora; A R Bianco; W Gullick; C A Angeletti; G Bevilacqua; F Ciardiello
Journal:  Clin Cancer Res       Date:  1998-01       Impact factor: 12.531

5.  Factors associated with the mammalian RNA polymerase II holoenzyme.

Authors:  A S Neish; S F Anderson; B P Schlegel; W Wei; J D Parvin
Journal:  Nucleic Acids Res       Date:  1998-02-01       Impact factor: 16.971

6.  Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines.

Authors:  I Martínez-Lacaci; M Saceda; G D Plowman; G R Johnson; N Normanno; D S Salomon; R B Dickson
Journal:  Endocrinology       Date:  1995-09       Impact factor: 4.736

7.  Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region.

Authors:  F Magdinier; S Ribieras; G M Lenoir; L Frappart; R Dante
Journal:  Oncogene       Date:  1998-12-17       Impact factor: 9.867

8.  BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A.

Authors:  S F Anderson; B P Schlegel; T Nakajima; E S Wolpin; J D Parvin
Journal:  Nat Genet       Date:  1998-07       Impact factor: 38.330

Review 9.  The role of amphiregulin in breast cancer.

Authors:  D S Salomon; N Normanno; F Ciardiello; R Brandt; M Shoyab; G J Todaro
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

10.  Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development.

Authors:  N C Luetteke; T H Qiu; S E Fenton; K L Troyer; R F Riedel; A Chang; D C Lee
Journal:  Development       Date:  1999-06       Impact factor: 6.868

View more
  13 in total

1.  Amphiregulin as a Novel Serum Marker of Puberty in Girls.

Authors:  Frank M Biro; Susan M Pinney; Richard C Schwartz; Bin Huang; Ashley M Cattran; Sandra Z Haslam
Journal:  J Pediatr Adolesc Gynecol       Date:  2017-02-16       Impact factor: 1.814

Review 2.  Contributions of Rad9 to tumorigenesis.

Authors:  Constantinos G Broustas; Howard B Lieberman
Journal:  J Cell Biochem       Date:  2012-03       Impact factor: 4.429

3.  Promoter methylation of AREG, HOXA11, hMLH1, NDRG2, NPTX2 and Tes genes in glioblastoma.

Authors:  Daina Skiriutė; Paulina Vaitkienė; Virginija Ašmonienė; Giedrius Steponaitis; Vytenis Pranas Deltuva; Arimantas Tamašauskas
Journal:  J Neurooncol       Date:  2013-04-28       Impact factor: 4.130

4.  Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression.

Authors:  Sonia de Assis; Anni Warri; Carlos Benitez; William Helferich; Leena Hilakivi-Clarke
Journal:  Cancer Prev Res (Phila)       Date:  2011-06-16

5.  Cyclin D1 determines estrogen signaling in the mammary gland in vivo.

Authors:  Mathew C Casimiro; Chenguang Wang; Zhiping Li; Gabriele Di Sante; Nicole E Willmart; Sankar Addya; Lei Chen; Yang Liu; Michael P Lisanti; Richard G Pestell
Journal:  Mol Endocrinol       Date:  2013-07-17

6.  BRCA1-Dependent Translational Regulation in Breast Cancer Cells.

Authors:  Estelle Dacheux; Anne Vincent; Nicolas Nazaret; Christophe Combet; Anne Wierinckx; Sylvie Mazoyer; Jean-Jacques Diaz; Joël Lachuer; Nicole Dalla Venezia
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

7.  Gross genomic alterations and gene expression profiles of high- grade serous carcinoma of the ovary with and without BRCA1 inactivation.

Authors:  Manohar Pradhan; Björn A Risberg; Claes G Tropé; Matt van de Rijn; C Blake Gilks; Cheng-Han Lee
Journal:  BMC Cancer       Date:  2010-09-15       Impact factor: 4.430

8.  Profiling of the BRCA1 transcriptome through microarray and ChIP-chip analysis.

Authors:  Julia J Gorski; Kienan I Savage; Jude M Mulligan; Simon S McDade; Jaine K Blayney; Zhaoping Ge; D Paul Harkin
Journal:  Nucleic Acids Res       Date:  2011-08-31       Impact factor: 16.971

Review 9.  Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cells.

Authors:  Francesco Acquati; Laura Monti; Marta Lualdi; Marco Fabbri; Maria Grazia Sacco; Laura Gribaldo; Roberto Taramelli
Journal:  Oncotarget       Date:  2011-06

10.  Identifying multi-layer gene regulatory modules from multi-dimensional genomic data.

Authors:  Wenyuan Li; Shihua Zhang; Chun-Chi Liu; Xianghong Jasmine Zhou
Journal:  Bioinformatics       Date:  2012-08-03       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.